Amarox KSA’s Post

Market Access Today is thrilled to announce its role as the official partner of the upcoming MENAHTA Forum 2024, a leading conference dedicated to Health Technology Assessment (HTA) excellence in the Middle East and North Africa (MENA) region. Scheduled for June 5th, 2024, at the prestigious Le Méridien Dubai Hotel + Conference Centre, this event promises to be a pivotal gathering for regulatory, market access, pricing, and commercial experts in the life sciences sector. The MENAHTA Forum 2024 is designed to educate and empower pharmaceutical industry decision-makers and distributors on the successful implementation of HTA in the MENA region. Attendees will gain critical insights into how HTA is shaping the future of healthcare and how it can drive commercial success during this transformative period. Key agenda highlights include discussions on the value approaches for innovative pharmaceutical products, HTA advancements and regional insights from Jordan, cost-effectiveness thresholds in the UAE, the importance of evidence generation for HTAs, and strategies for implementing value-based technology assessments. As the official partner, Market Access Today is proud to support this essential forum, which aligns with our commitment to fostering innovation and excellence in healthcare. We invite pharmaceutical professionals, distributors, and wholesalers to join us for this enlightening event to enhance their knowledge and strategies for market access in the MENA region. For more information: https://lnkd.in/drwTFYD5 Special Offer: Attendees can enjoy a 15% discount on registration by using the code "ZAG15". Register now to secure your spot at the MENAHTA Forum 2024, and prepare to engage in insightful discussions that will undoubtedly influence the future of healthcare in our region. We look forward to welcoming you and contributing to a day of significant learning and networking opportunities. #menahta #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #pharmacoeconomics #health #pharmaceuticals #medicaldevices #HTA #MENA

 Agon at CPHI Middle East in Riyadh, Saudi Arabia! We were honored to participate in this transformative event, engaging with partners, industry leaders, and new connections to shape the future of healthcare and pharmaceuticals.  Watch Our Video! Experience the highlights of Agon’s journey at CPHI Middle East! From inspiring panel discussions to meaningful connections, witness the energy and innovation that drove this incredible event. Click below to watch!  Panel Discussions We Were Honored to Join:  Pharmaceutical Localization and Sustainable Access to High-quality Healthcare  This panel focused on strategies to enhance local pharmaceutical manufacturing and ensure sustainable access to quality healthcare products.  Speakers: Yara Almouti Amgad Talaat Fahad AlButhi Ashraf Al Grain  Regional Spotlight – Oman  A deep dive into Oman’s pharmaceutical potential, highlighting regional advancements and opportunities in healthcare.  Speakers: Yara Almouti Hamid Saif Al-Sabahi Sofie Tolk Damith D.  Scaling Up Digital Innovation: Revolutionizing R&D to Patient Care within the Pharma Industry (CME Accredited)  Discussed cutting-edge digital innovations transforming the journey from R&D to patient care in the pharma industry.  Speakers: Yara Almouti Dr Nadia Cheaib Abdulaziz Alhomod MD, MS, FACEP, FAMIA @GloriaLam  Paving the Way for Young Pharmacists to Enter the Pharmaceutical Industry: Building Capacity and Incentive Programs (CME Accredited)  Explored initiatives to empower young pharmacists through capacity-building programs and industry incentives.  Speakers: Yara Almouti Vivien Santillan Dr Nadia Cheaib Venus Elrayes  We extend our deepest gratitude to everyone who made this event a success, Together, we are paving the way for a brighter future in healthcare! #AgonAtCPHI #CPHIMiddleEast #PharmaInnovation #PharmaLeaders #SustainableHealthcare #DigitalTransformation #R&DEvolution #YoungPharmacists #PharmaNetworking #RiyadhEvents #PharmaLocalization #FutureOfHealthcare #AgonPharma #PharmaLeadership #GlobalHealthcare #HealthcareInnovation #LifeSciences #PharmaTrends #PharmaEvent #HealthcareLeaders #PharmaGrowth #CPHISaudiArabia #PharmaceuticalDevelopment #PharmaOpportunities #GlobalNetworking #AgonWorldwide #BetterHealthcare #EmpoweringPharmacists #InnovativePharma #MiddleEastPharma #PharmaIndustryEvents

The collaboration between Eva Pharma and Ebn Sina in Qatar, marks a huge step toward registering new pharmaceutical and healthcare products in the “GCC & Algeria cluster” to ensure the well-being state of patients in Qatar. We are very excited to start the registration step of the products in Qatar after having worked on registering our manufacturing sites and we are expecting the receipt of the GMPs very soon 😉

Thank you to the esteemed industry leaders and experts – Alaa Darwish, Dr Srikanth Rajagopal, Mohamed Amir, Firat Incioglu, Rina Chotai, and Hasan Kapar – for joining us at the Waldorf Astoria DIFC in Dubai for a thought-provoking roundtable discussion on "Unlocking the Market: Strategies for Pharmaceutical Pricing, Access, and Tenders in the GCC" earlier this month. The event provided a valuable platform to examine the critical role of national tenders in improving access to safe and effective medicines across the region. Experts engaged in an insightful dialogue on the current state of tender practices, delving into the evolution of these systems and their impact on the pharmaceutical industry, particularly in relation to various drug types. The conversation also focused on identifying key principles and best practices for designing a national tender system that ensures fair pricing, accessibility, and operational efficiency. Stay tuned for a report highlighting the key discussion topics and emerging trends. Discover more about Clarivate’s market-leading intelligence and transformative data technology here: https://lnkd.in/gD-vvkum #Pharmaceuticals #MarketAccess #Healthcare #Tenders #PharmaStrategy #HealthcareInnovation #Dubai

As vendors to Novartis Saudi Arabia | نوفارتس السعودية and IQVIA Middle East and Africa, we are happy to share the findings of our #RWE study with the medical community. This study was led by Dr. Ibrahim Al-Homod, MD,FACP, consultant internal medicine, esteemed Rheumatologist and Chairman of the postgraduate department at King Fahad Medical City - KFMC. We determined the “treatment retention rate” to check the percentage of patients who continued to use the drug over 6 and 12 months. The percentage of treatment retention after 6 months was 100%. Considering the patients who started secukinumab 12 months or more prior to the study cutoff date (December 2022), the 12-month retention rate was 85%. DAPSA score showed a statistically significant decrease among those who received secukinumab alone by approximately 20.9 and 21.4 (p values < 0.001 for each) compared to 23.7 and 25.9 in combination with MTX (p-value = 0.012 & 0.006, respectively) after 6 and 12 months of treatment, respectively, compared to the baseline. read more (link in the comments)!

Arab Health Exhibition 2025 is scheduled from January 27 to 30 at the Dubai World Trade Centre. India is set to have a significant presence at Arab Health 2025, scheduled from January 27 to 30 at the Dubai World Trade Centre. The Pharmexcil (Pharmaceuticals Export Promotion Council of India) will organize the India Pavilion, marking its 17th consecutive year of participation. This pavilion will showcase a diverse range of Indian healthcare products, including surgical equipment, medical devices, herbal products, pharmaceuticals, and nutraceuticals. Additionally, the Engineering Export Promotion Council (EEPC) of India is facilitating Indian medical device manufacturers and distributors to tap into the abundant opportunities at the event. Their participation aims to strengthen India’s footprint in the Middle Eastern healthcare market. Arab Health 2025 is anticipated to feature over 3,450 exhibitors from more than 70 countries, including numerous international pavilions. The event serves as a pivotal platform for Indian companies to explore business prospects, forge partnerships, and showcase their innovations to a global audience. https://lnkd.in/giuxTvNW

Yesterday, we received the latest MAT report from IQVIA, and the numbers are impressive! The UAE pharmaceutical market is currently valued at $4.1 billion USD, with a growth rate of 16.5%. This dynamic growth showcases the UAE's commitment to advancing healthcare and pharmaceutical innovation. What Insights I could drive were: Alimentary Tract and Metabolism: Leading the market, reflecting the increasing focus on gastrointestinal health and diabetes management. Retail Pharmacy Boom: Contributing significantly to overall market growth, driven by rising consumer awareness and demand for OTC products. Surge in Innovative Treatments: Especially in chronic disease management, with companies investing heavily in research and development. Government Support: Playing a pivotal role in healthcare sector growth through policies promoting investment and establishment of world-class medical facilities. Digital Health Solutions: Telemedicine and e-pharmacies are becoming integral parts of the healthcare system, enhancing patient access to services and medications. At Morphosis, we are committed to leveraging these insights to drive effective pharmaceutical marketing strategies. By understanding market trends and consumer behavior, we create targeted campaigns that resonate with healthcare professionals and patients alike. Our goal is to help our clients navigate this dynamic landscape and achieve sustainable growth. #pharmaceuticalmarketing #healthcareinnovation #UAEpharma #marketinsights #voiceofmorphosis #pharmaceuticalmarketingagency

🚀  Biosimilars LatAm - Brazil 2024 will feature a high-level panel to discuss strategies for improving biosimilars access in Brazil. Our speakers include Francisco Javier D., Andre Luiz Jochen, and Paulo Fernandes who will share their expertise and experiences to find innovative solutions. They will also provide in-depth analysis and future strategies to enhance biosimilars access 🌟 🗓️ Date: August 21-22, 2024  📍 Venue: Pullman Ibirapuera #SãoPaulo Hotel There are only 8 days left until this crucial forum begins. Don’t miss out—Register Now! 🚨  https://lnkd.in/d5RTHdk2 If you are affiliated with any of the following organizations, please contact us for a discount code: 🤝 ABIFINA, ABIQUIFI, ABRACRO, Alianza de CROs de Mexico (ACROM), ALANAC - Associação dos Laboratórios Farmacêuticos Nacionais, AMELAF, Amepres México, CANIFARMA, CAPGEN - Cámara Argentina de Productores de Medicamentos Hospitalarios, IGBA - International Generic and Biosimilar medicines Association, PróGenéricos, SINDIFARGO, União Farmacêutica de São Paulo - UNIFAR #BiosimilarsForum #Brazil2024 #Healthcare #AccessToMedicines

The pharmaceutical industry's future is shaped by the connections we build and the ideas we exchange. That’s why we’re thrilled to have one of our team members on the ground at CPHI Middle East this year. Are you attending? Let’s meet and talk about how innovation in marketing can help shape the future of the pharmaceutical and healthcare industries. #CPHIMiddleEast #Innovation #Collaboration #HealthcareMarketing

Abu Dhabi DoH Leads with Early Access to Groundbreaking Pulmonary Arterial Hypertension Medication In a groundbreaking move, Abu Dhabi's Department of Health Abu Dhabi has granted early access to WINREVAIR, a cutting-edge medication for Pulmonary Arterial Hypertension (PAH). This initiative marks a pivotal moment, as Abu Dhabi becomes the first in the region to introduce this innovative treatment, bringing new hope to patients battling this life-threatening condition. Dr. Asma Al Mannaei emphasized the significance of this step, stating, "Such initiatives reinforce Abu Dhabi's position as a global healthcare leader." WINREVAIR has earned approval from both the FDA and Emirates Medical Association, cementing its role as a transformative therapy. Ashraf Mallak of MSD GCC hailed this collaboration, noting, "This partnership marks a new hope for patients living with this disease in the UAE." Read more at, https://lnkd.in/dSyyEvAB | The Health Colossus #healthcare #pharmaceutical #drugs #middleeast #UAE #abudhabi #PAH #WINREVAIR #thehealthcolossus